PetMed Express, Inc. to Report Fourth Quarter and Fiscal Year 2026 Financial Results on Tuesday, June 2, 2026
PetMed Express (Nasdaq:PETS), doing business as PetMeds and parent of PetCareRx, will report Q4 and fiscal year 2026 results for the period ended March 31, 2026, on Tuesday, June 2, 2026 after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
PetMed Express (Nasdaq:PETS), doing business as PetMeds and parent of PetCareRx, will report Q4 and fiscal year 2026 results for the period ended March 31, 2026, on Tuesday, June 2, 2026 after market close.
A conference call and webcast follow at 4:30 PM ET.
Details
News Market Reaction – PETS
On May 29, the day this news came out, PETS closed 1.36% below the previous close.
Data tracked by StockTitan Argus for the May 29 session.
Key Figures
- Earnings date
- June 2, 2026
- Fourth quarter and fiscal year 2026 results release date
- Quarter end
- March 31, 2026
- Fiscal quarter and year end for upcoming results
- Conference call time
- 4:30pm Eastern Time
- Scheduled time for earnings call on June 2, 2026
- U.S. dial-in
- 877-407-0789
- Domestic access number for the earnings call
- International dial-in
- 201-689-8562
- International access number for the earnings call
- Replay window end
- June 16, 2026
- Final date for telephonic replay availability
- Replay toll-free
- 844-512-2921
- Toll-free number for conference call replay
- Replay passcode
- 13760873
- Access code required for conference call replay
Historical Context
-
Announced Rural King white-label pet pharmacy across retail and digital channels.
-
Unsolicited all-cash proposal at $4.25 per share implying $89M equity value.
-
Unsolicited non-binding $4.00 per share cash proposal from SilverCape Investments.
-
Launch of 2025 wellness-focused holiday collection for pets and pet parents.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
DELRAY BEACH, Fla., May 29, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) today announced it will report financial results for the fourth quarter and fiscal year ended March 31, 2026, on Tuesday, June 2, 2026 after market close. The Company will host a conference call and webcast to discuss these results at 4:30pm Eastern Time on the same day.
Date: Tuesday, June 2, 2026
Time: 4:30pm Eastern Time (1:30pm Pacific Time)
U.S. dial-in number: 877-407-0789
International number: 201-689-8562
Webcast: 4Q Earnings Webcast
A telephonic replay of the conference call will also be available after 7:30 PM Eastern Time on the same day through June 16, 2026.
Toll-free replay number: 844-512-2921
International replay number: 412-317-6671
Replay passcode: 13760873
About PetMed Express, Inc.
Founded in 1996, PetMeds is a pioneer in the direct-to-consumer pet healthcare sector. As a trusted national online pharmacy, PetMeds is licensed across all 50 states and staffed with expert pharmacists dedicated to supporting pet wellness, pets and pet parents, and the veterinarians who serve them. Through its PETS family of brands and through its PetCareRx subsidiary, the Company offers a comprehensive range of pet health solutions - including top-brand and generic pharmaceuticals, compounded medications, and better-for-your-pet OTC supplements and nutrition. Focused on value, convenience, and care, PetMeds and PetCareRx empower pet parents to help their dogs, cats, and horses live longer, healthier lives. To learn more, visit www.PetMeds.com and www.PetCareRx.com.
Investor Contact:
ICR, LLC
Reed Anderson
(646) 277-1260
investor@petmeds.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.